Teva Pharmaceutical Industries Limited (TEVA) Release: The Potential for New Therapeutic Approaches: Global Research Collaboration Examines Multiple Pathways of Neuroprotection in Huntington Disease
7/29/2013 9:30:51 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced the formation of a global scientific research collaboration to create a comprehensive understanding and drive insights into neuroprotective therapeutic approaches in Huntington disease (HD).
Help employers find you! Check out all the jobs and post your resume.
comments powered by